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Abstract
Many of the factors that contribute to CD8+ T cell immunodominance hierarchies during viral infection are known. However,
the functional differences that exist between dominant and subdominant epitope-specific CD8+ T cells remain poorly
understood. In this study, we characterized the phenotypic and functional differences between dominant and subdominant
simian immunodeficiency virus (SIV) epitope-specific CD8+ T cells restricted by the major histocompatibility complex (MHC)
class I allele Mamu-A*01 during acute and chronic SIV infection. Whole genome expression analyses during acute infection
revealed that dominant SIV epitope-specific CD8+ T cells had a gene expression profile consistent with greater maturity and
higher cytotoxic potential than subdominant epitope-specific CD8+ T cells. Flow-cytometric measurements of protein
expression and anti-viral functionality during chronic infection confirmed these phenotypic and functional differences.
Expression analyses of exhaustion-associated genes indicated that LAG-3 and CTLA-4 were more highly expressed in the
dominant epitope-specific cells during acute SIV infection. Interestingly, only LAG-3 expression remained high during
chronic infection in dominant epitope-specific cells. We also explored the binding interaction between peptide:MHC
(pMHC) complexes and their cognate TCRs to determine their role in the establishment of immunodominance hierarchies.
We found that epitope dominance was associated with higher TCR:pMHC affinity. These studies demonstrate that
significant functional differences exist between dominant and subdominant epitope-specific CD8+ T cells within MHC-
restricted immunodominance hierarchies and suggest that TCR:pMHC affinity may play an important role in determining
the frequency and functionality of these cell populations. These findings advance our understanding of the regulation of T
cell immunodominance and will aid HIV vaccine design.
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Introduction
Virus-specific CD8+ T cells contribute to the control of HIV
and SIV replication [1,2] and are therefore an important
component of a protective immunity. In infected or vaccinated
individuals, the frequencies of different viral epitope-specific CD8+
T cells vary considerably [3,4]. Epitopes restricted by the same
MHC Class I allele can be ranked in an immunodominance
hierarchy based on the relative frequencies of their respective
epitope-specific CD8+ T cells [5]. The determinants of immuno-
dominance hierarchies have been explored in the past in efforts to
enhance the magnitude of particular epitope-specific CD8+ T cell
responses through vaccination [6,7]. However, such investigations
have primarily focused on determining the mechanisms underly-
ing the establishment of immunodominance [8–12]; less is known
about the resulting functional differences between dominant and
subdominant epitope-specific CD8+ T cells.
CD8+ T cell polyfunctionality is often associated with superior
viral control [13]. Numerous studies have reported that individuals
with superior control of HIV replication and delayed disease
progression have higher frequencies of polyfunctional CD8+ T
cells and therefore such cells are thought to be an important
component of a protective immune response during HIV infection
[14–17]. Therefore, HIV vaccine development is particularly
focused on the identification of vaccine strategies that will generate
highly polyfunctional, and therefore protective, responses [18]. In
order to do so, a better understanding of the factors that contribute
to the polyfunctionality of a CD8+ T cell response is needed.
Few studies have evaluated the functional differences between
dominant and subdominant epitope-specific CD8+ T cells. Studies
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in DNA-immunized mice showed that subdominant epitope-
specific CD8+ T cells were less cytotoxic, but produced more
cytokines, than dominant epitope-specific CD8+ T cells during
acute infection [19]. Moreover, a cryptic epitope-specific CD8+ T
cell population exhibited an altered maturation phenotype when
compared to cells comprising the dominant response [20]. A study
of the functionality of CD8+ T cells within the HLA-B27-restricted
immunodominance hierarchy in HIV-infected individuals found
higher-frequency epitope-specific CD8+ T cells were associated
with superior in vitro viral suppression; although, subsequent
functional studies could not identify a particular function
associated with this suppressive capacity [21]. Additional knowl-
edge of functional differences between dominant and subdominant
epitope-specific CD8+ T cell responses is needed for enhancing
CD8+ T cell epitope-specific responses by vaccination.
In the present studies, we performed longitudinal gene
expression analysis in SIV-infected Mamu-A*01+ rhesus monkeys
to assess potential functional differences between dominant and
subdominant epitope-specific CD8+ T cells during acute infection.
We demonstrate that dominant epitope-specific CD8+ T cells
display gene expression patterns consistent with a more mature
phenotype and harbor greater cytotoxic potential than subdom-
inant epitope-specific CD8+ T cells during acute infection. Protein
expression analyses of CD8+ T cells sampled during chronic
infection confirmed the presence of these functional differences
between dominant and subdominant epitope-specific CD8+ T
cells. Finally, dominant and subdominant epitope TCR:pMHC
affinities were correlated with relative immunodominance. These
findings advance our understanding of the basis underlying
immunodominance and may better inform T cell-based HIV
vaccine design.
Results
p11C- and p54AS-specific CD8+ T cell frequencies and
viral loads during acute SIVmac251 infection
We infected six Mamu-A*01+ rhesus monkeys with SIVmac251.
The Mamu-A*01-restricted dominant SIV Gag p11C- and
subdominant SIV Env p54AS-specific CD8+ T cells were
quantified and sorted by flow cytometry on days 14, 21, 28, 35,
42, 56, and 70 post-inoculation. The Mamu-A*01-restricted CD8+
T cell response is one of the best characterized CD8+ T cell
responses in SIV-infected rhesus monkeys [22,23]. The p11C
epitope (Gag CM9) has been used widely as a model dominant
epitope in studies of SIV-specific immunity [24–26]. p54AS (Env
TL9) is a well-described subdominant epitope that, from our
experience, was the most likely to be elicited in all Mamu-A*01+
rhesus monkeys at a frequency that was high enough such that we
could collect sufficient numbers of cells to facilitate our gene
expression measurements.
The differences in frequency between the p11C- and p54AS-
specific CD8+ T cells were apparent upon detection in the
peripheral blood (day 14) and were maintained throughout the
duration of infection (Figure 1A and Figure S1). The plasma viral
loads peaked at approximately 7 logs of viral RNA copies/mL by
day 14 and reached setpoint of approximately 5.5 logs of viral
RNA/mL by day 28 (Figure 1B).
We measured RNA expression on the sorted epitope-specific
cell populations at various timepoints post infection. We also
sorted total naı¨ve CD8+ T cells (CD952CD28+) before challenge
(day 0) and measured RNA expression in these cells to establish a
baseline expression level for each transcript. We generated
expression data from both epitope-specific cell populations from
all six monkeys only on days 14, 21, 56 and 70. We obtained
expression data for both epitope-specific populations in only some
of the monkeys on the three other time points: days 35 and 42 (4 of
6 monkeys) and day 28 (5 of 6 monkeys). Therefore, sometimes we
observed trends suggesting differential expression (Figure S2) that
did not achieve statistical significance possibly due to reduced
power.
To characterize the functional differences between the domi-
nant p11C- and subdominant p54AS-specific cells based on their
RNA expression profiles, we focused expression analysis on genes
known to be associated with specific CD8+ T cell functions. These
genes were grouped into the following categories: maturation,
cytotoxicity, cell cycle and apoptosis, and cytokines and chemo-
kines (Table 1). Genes were considered differentially expressed if
they satisfied both of the following criteria: 1) expression was
significantly different between the two epitope-specific cells on at
least one timepoint and 2) the median fold difference of expression
at this timepoint (p11C/p54AS) was at least 61.5. Technical
replicates were not conducted; gene expression was measured once
per monkey per timepoint.
Maturation-associated gene expression
Of the genes involved in CD8+ T cell maturation, IL7R
(CD127/IL-7 receptor, refseq accession # XM_937367.1), SELL
(CD62L/L-selectin, NM_000655.3), and CCR7 (NM_001838.2)
met our criteria for differential expression following SIV infection
(Figure 2A). While the trends of expression of these three genes
between p11C- and the p54AS-specific cells were similar over
time, all of these genes were found to be expressed at relatively
higher levels in the subdominant p54AS-specific cells compared
to the dominant p11C-specific cells. IL7R expression was higher
in the p54AS-specific cells with significant fold differences of 1.8
on day 14, 1.5 on day 56, and 1.9 on day 70. SELL expression
was also higher in the p54AS-specific cells with significant fold
differences of 1.8 on day 14, 2.0 on day 21, and 1.7 on day 56.
CCR7 was more highly expressed in the p54AS-specific cells
with a significant fold difference of 2.4 on day 14. While the
expression of IL7R and SELL tended to be higher in the p54AS-
specific cells for all timepoints examined, the expression for CCR7
appeared only to be different on day 14 (Figure 2A and Figure
S2A).
Author Summary
MHC-restricted CD8+ T cell populations that bind viral
proteins are often present at different frequencies. It is
thought that those virus-specific CD8+ T cells that are
present at the highest frequency are predominantly
responsible for eliciting control of viral infections. While
the number of virus-specific CD8+ T cells is undoubtedly
important, the functionality of these cells may also play an
anti-viral role. It is not known if high-frequency virus-
specific CD8+ T cells are more functionally effective against
viral infection than those present at low frequencies. In this
study, we characterized the functional differences between
the SIV-specific cells present at high versus low frequencies
in rhesus monkeys infected with simian immunodeficiency
virus (SIV). We found that the high- and low-frequency SIV-
specific cells had different functional capacities during
acute and chronic SIV infection. We also found that the
affinity with which a cell interacts with viral proteins may
contribute to these functional differences. These findings
further our understanding of anti-viral immune responses
and may help to inform HIV vaccine development.
TCR Affinity and CTL Immunodominance Hierarchies
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Cytotoxicity-associated gene expression
Of the genes involved in cytotoxicity, GZMB (granzyme B,
NM_004131.3), GZMK (granzyme K, NM_002104.2), and
LAMP2 (CD107b, NM_013995.1) met our criteria for differential
expression following SIV infection (Figure 2B). LAMP2 was
measured on the BeadChip by three different probes, two of
which measured differential expression (probes 1659753 and
1752351). Expression levels of each of the three cytotoxicity-
associated genes were found to be increased in the dominant
p11C-specific cells compared to the subdominant p54AS-specific
cells. On day 14, the p11C-specific cells exhibited higher
expression of both GZMB (significant fold difference of 1.5) and
GZMK (significant fold difference of 1.9). Although the trends in
differential expression of these two granzyme genes were still
apparent on day 21 and 28, differences were subsequently lost
(Fig. 2B and Figure S2B). The two LAMP2 probes detected similar
trends of expression of this gene. However, probe 1659753
detected significant differential expression on day 14 (1.5-fold)
while probe 1752351 detected significant differential expression on
day 70 (1.8-fold).
Cell cycle and apoptosis-associated gene expression
Of the cell cycle and apoptosis-associated genes, nine met our
criteria for differential expression following SIV infection
(Figure 2C and Figure S2C). Two of these genes, BIRC3 (AIP1/
API2/c-IAP2, NM_001165.3) and CASP2 (caspase-2,
NM_032983.2), are involved in apoptosis. BIRC3, which encodes
a protein with multiple anti-apoptotic functions [27], was
differentially expressed on day 14, showing 1.8-fold higher
expression in the p54AS-specific cells. CASP2, which encodes a
pro-apoptotic protease [28], was differentially expressed on day
14, showing 1.7-fold higher expression in the p11C-specific cells.
The remaining seven differentially expressed genes are involved
in proliferation: UBE2C (ubiquitin-conjugating enzyme E2C,
NM_181800.1), AURKB (aurora B kinase, NM_004217.2), CCND2
(cyclin D2, NM_001759.2), CDC42 (cell division cycle 42,
NM_001039802.1), NUSAP1 (nucleolar and spindle associated
protein 1, NM_018454.5), UHRF1 (ubiquitin-like with PHD and
ring finger domains 1, NM_001048201.1), and ATM (ataxia
telangiectasia, NM_000051.3). UBE2C and AURKB encode pro-
proliferative genes involved in the regulation of the anaphase-
promoting complex [29,30]; both were more highly expressed in
the p11C-specific cells on day 56 with 1.6- and 1.5- fold
differences, respectively. CCND2, CDC42, NUSAP1, and UHRF1
also encode pro-proliferative genes [31–35]. All of these genes
showed differential expression on day 70 and were more highly
expressed in the p11C-specific cells: CCND2 by 1.6-fold, CDC42 by
1.9-fold, NUSAP1 by 2.7-fold, and UHRF1 by 2.5-fold. Finally,
ATM, an anti-proliferative serine/threonine protein kinase [36],
was differentially expressed on day 21 and was more highly
expressed in the p54AS-specific cells with by 1.5-fold.
In summary, we detected differential expression of genes
involved in CD8+ T cell maturation, cytotoxicity, and cell cycle
and apoptosis suggesting that functional differences may exist
between the dominant p11C-specific and the subdominant
p54AS-specific cells. Decreased expression of the genes encoding
CD127, CD62L, and CCR7 and the increased expression of genes
encoding granzyme B, granzyme K, and CD107b (LAMP2) in the
dominant p11C-specific cells compared to the subdominant
p54AS-specific cells suggested that the p11C-specific cells were
more mature and possessed greater cytotoxic potential than the
p54AS-specific cells. Moreover, we observed that the p11C-
specific cells had higher expression of pro-proliferative genes and
an increased expression of a pro-apoptotic molecule.
The dominant epitope-specific CD8+ T cell population
was enriched with cells that exhibit a more mature
phenotype
Functional assays were performed on PBMCs isolated from
chronically infected monkeys to confirm and extend the observa-
tions of differential gene expression patterns. In addition to the
dominant p11C- and subdominant p54AS-specific cells, we
studied an additional CD8+ T cell population of even lower
frequency that recognizes the Mamu-A*01-restricted SIV Pol
p68A (STPPLVRLV, Pol SV9621) subdominant epitope [23].
Additionally, we analyzed cells from monkeys infected with a
different SIV isolate, SIVsmE660 [37]. The p54 epitope from the
SIVsmE660 (TVPWPNETL) virus differs by two amino acids
from the p54 epitope from SIVmac251 (TVPWPNASL) virus [22]
and we refer to this epitope as p54E660. The immunodominance
hierarchy of the p11C-, p54AS/E660-, and p68A-specific cells
during chronic SIVsmE660 infection was similar to SIVmac251-
infected monkeys (Figure 3A and Figure S3).
Figure 1. Frequencies of p11C- and p54AS-specific CD8+ T cells and plasma viral loads during primary infection. A) Mean frequencies
of the p11C- and p54AS-specific CD8+ T cells in peripheral blood. * significant at p#0.05. B) Plasma SIV RNA levels in the peripheral blood.
doi:10.1371/journal.ppat.1004069.g001
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Table 1. Genes compared between dominant and subdominant epitope-specific CD8+ T cells.
Maturation Cytotoxicity
Cytokines and
Chemokines Cell Cycle and Apoptosis
B3GAT1 AP3B1 CCL3 AIFM1 BRCA2 CDKN1A HDAC2 NAIP SMAD2
BCL6 C1ORF9 TNFSF11 AIFM2 BTRC CDKN1B HDAC3 NCAPD2 SMAD3
BMI1 CSPG5 CCL7 AKT1 CABIN1 CDKN1C HRAS NCAPG SMAD4
CCR7 CTSC CCL4 ANAPC1 CASP1 CDKN2A HRK NCAPH SMAD5
CD27 EBAG9 CCL5 ANAPC10 CASP10 CDKN2B HTRA2 NFKB1 SMAD6
CD28 GNLY TGFB1 ANAPC11 CASP12 CDKN2C HUS1 NFKB2 SMAD7
CXCR3 GZMA IL12A ANAPC13 CASP2 CDKN2D ID1 NOL3 SMAD9
EOMES GZMB MIF ANAPC16 CASP3 CEBPA ID2 NRAS SMC2
GFI1 GZMH IL22 ANAPC2 CASP6 CEBPB ID3 NUSAP1 SMC4
ID2 GZMK IL16 ANAPC4 CASP7 CENPF ID4 PCNA SNRPE
IL2RA IQGAP1 IL26 ANAPC5 CASP8 CFLAR IGF1 PEA-15 SOD2
IL7R JAKMIP1 IL29 ANAPC7 CASP9 CHEK1 IGFBP3 PKMYT1 SP1
ITGAL LAMP2 IL1A APAF1 CCNA1 CHEK2 IRF1 PLK1 STK11
KLF2 LYST IFNW1 APC CCNA2 CKS1B IRF2 PMAIP1 SUV39H1
KLRG1 M6PR IL10 ARAF CCNB1 CKS2 IRF3 PPARA TACC3
MBD2 PRF1 SPP1 ARHGAP19 CCNB2 CPEB1 IRF4 PPKACA TCL1A
PRDM1 RAB27A TNFSF14 ATM CCNC CUL1 IRF8 PPKACB TERT
SELL SMPD1 IFNB1 ATR CCND1 DAP IRF9 PRKAR1A TFDP1
SPN SNAP23 XCL2 AURKB CCND2 DAXX JUN PRKAR1B TFDP2
TBX21 SNAP25 XCL1 BAD CCND3 DIABLO JUNB PRKAR2A THAP5
XBP1 SRGN OSM BAK1 CCNDBP1 DLG1 KAT2B PRKAR2B TNFR1
STOML2 CX3CL1 BARD1 CCNE1 DLG3 KIT PRKDC TNFRSF10A
STX11 CCL20 BAX CCNE2 DLG4 KLF10 PRPS1 TNFRSF10B
STXBP2 IL17D BBC3 CCNF E2F1 KLF4 RAC1 TNFRSF21
SYTL1 IL17F BCL2 CCNG2 E2F2 KLF5 RAD1 TNFRSF25
SYTL2 IL17A BCL2A1 CCNH E2F3 KLF6 RAF1 TNFSF10
TFF1 IFNG BCL2L1 CDC16 E2F4 KRAS RALA TP53
TRIP10 LTB BCL2L10 CDC20 E2F5 MAP2K1 RALB TP53AIP1
UNC13D LTA BCL2L11 CDC23 E2F6 MAP2K2 RALGDS TP73
VAMP7 TNF BCL2L14 CDC25A E2F7 MAP3K5 RB1 TRADD
VAMP8 FASLG BCL2L2 CDC25B ECT2 MAP3K7 RBL1 TRAF2
CXCL11 BCL3 CDC25C EGR1 MAPK1 RBL2 TRIM25
CXCL10 BCL6 CDC27 EIF4EBP1 MAPK14 REL TSC1
IL18 BID CDC2L2 ENDOG MAPK7 RELA TSC2
CXCL5 BIK CDC42 EP300 MAX RELB TSC22D1
IRF4 BIN1 CDC42EP4 FADD MCL1 RGL1 TTK
CCL18 BIRC2 CDCA8 FAS MDM2 RGL2 UBE2C
IFNA1 BIRC3 CDK1 FASLG MDM4 RHEB UHRF1
IL13 BIRC5 CDK10 FBX05 MEF2A RHEBL1 WEE1
CSF2 BIRC6 CDK11A FLT3 MEF2B RHOA XIAP
IL6 BIRC7 CDK11B FOSL1 MEF2C RING1 YWHAB
CXCL9 BIRC8 CDK13 FOSL2 MEF2D RPS6KB1 YWHAE
IL4 BLK CDK16 FOXO1 MGA RPS6KB2 YWHAG
IL5 BMF CDK2 FOXO3 MKI67 RRAS YWHAH
IL2 BNIP3 CDK3 FOXO4 MNAT1 RRAS2 YWHAQ
IL3 BNIP3L CDK4 FZR1 MXD1 SCRIB YWHAZ
IL8 BOK CDK5 GABPA MXD3 SFN YY1
BRAF CDK6 GADD45A MYB SKP2 ZMIZ1
BRCA1 CDK7 HDAC1 MYC SMAD1
doi:10.1371/journal.ppat.1004069.t001
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The maturation of tetramer-positive cell populations from
SIVmac251- and SIVsmE660-infected monkeys was determined
by measuring the surface expression of CCR7 and CD28. Cells
were categorized as central memory (CCR7+CD28+), transitional
memory (CCR72CD28+), or fully differentiated effector memory
(CCR72CD282) as previously described for rhesus monkeys [38].
All tetramer-positive cells were CD95+ (not shown). The dominant
p11C-specific cells displayed a greater proportion of the more
mature effector memory phenotype (CCR72CD282) compared to
the subdominant p54AS-specific cells (Figure 3B and Figure S4).
This is consistent with gene expression studies in SIVmac251-
infected monkeys that expressed CCR7, CD62L, and SELL at lower
levels in the p11C-specific cells, suggesting they were more mature
than the p54AS-specific cells.
Additionally, we found that the more subdominant p68A-
specific cells were phenotypically less mature compared to the
subdominant p54AS/E660-specific cells (Figure 3B). Of the three
epitope-specific cell populations, the p68A-specific population was
the most enriched with cells of the less mature phenotypes and
were the least enriched with cells of the mature effector memory
phenotype. This trend was observed in both SIVmac251- and
SIVsmE660-infected monkeys. While the distribution of pheno-
types was similar between cells from SIVmac251- and
SIVsmE660-infected monkeys, the sample size for SIVmac251
(n = 4) was much smaller than that of SIVsmE660 (n = 8) and was
not sufficiently powered to detect significance.
To confirm that differences in gene expression of cytolytic
molecules were similarly reflected in protein production, we
measured the intracellular content of perforin and granzyme B
within each tetramer-positive population. The dominant p11C-
specific populations had a greater frequency of cells containing
perforin and granzyme B than the subdominant p54AS/E660-
specific population, which in turn had a greater frequency of
perforin- and granzyme B-containing cells than the subdominant
p68A-specific population (Figure 3C and Figure S5). The p11C-
specific cells also contained more perforin and granzyme B per-cell
(reflected by higher geometric mean fluorescence (GMF)) than the
p54AS/E660-specific cells, which in turn contained more of these
proteins than the p68A-specific cells (Figure 3D and Figure S5).
These observations were consistent with previous findings that
demonstrated not only that more mature cells are more likely to
express perforin and granzymes [39], but also that more mature
cells have more perforin and granzyme per cell than less mature
cells [40].
The dominant p11C-specific CD8+ T cells exhibited
decreased antigen-specific expansion compared to
subdominant epitope-specific CD8+ T cells
Although differences in expression of genes involved in cell cycle
and apoptosis were observed, it was unclear what impact these
genes had on cell expansion upon antigen stimulation during
chronic infection. To explore this, PBMCs from monkeys chron-
ically infected with SIVmac251 or SIVsmE660 were peptide-
stimulated and expansion of the epitope-specific cells was assessed
over 14 days. We found that the dominant p11C-specific cells had
reduced capacity to expand when compared to both of the
subdominant epitope-specific cells (Figure 4 and Figure S6). This
trend was consistent between cells from SIVsmE660- and
SIVmac251-infected monkeys and is in agreement with prior
reports that effector memory CD8+ T cells have limited proliferative
capacity compared to less mature memory CD8+ T cells [41].
The dominant p11C-specific CD8+ T cell population
contained a lower frequency of cytokine- and
chemokine-producing cells than the subdominant
epitope-specific CD8+ T cell populations
Our gene expression data did not demonstrate differences in
cytokine or chemokine expression between the p11C- and p54AS-
specific cells. However, cytokine genes often require re-stimulation
immediately prior to measurement [42]. Therefore, we considered
that differences in cytokine expression between dominant and
subdominant epitope-specific cells might be observed following
antigen stimulation. To investigate, we stimulated PBMCs with
epitope peptides and measured IL-2, TNFa, IFNc, and MIP1-b
production in standard intracellular cytokine staining (ICS) assays
(Figure S7). Lower frequencies of cells expressing each of these
cytokines and chemokines were present in the dominant p11C-
specific cell population compared to the subdominant epitope-
specific cell populations (Figure 5A). Furthermore, the subdomi-
nant epitope-specific populations were more polyfunctional,
exhibiting larger proportions of cells expressing three or four
functions, compared to the dominant p11C-specific population
(Figure 5B and 5C).
Expression of exhaustion-associated genes in dominant
and subdominant CD8+ T cells
To assess differences in functionality that may be due to
different extents of exhaustion, we compared the expression of
genes encoding exhaustion-associated molecules between the
p11C- and p54AS-specific cells during acute infection (day 14),
at the onset of chronic infection (day 70), and during late chronic
infection (week 31 or 32). The genes LAG3 (NM_002286.4) and
CTLA4 (NM_005214.3) were significantly more highly expressed
in the dominant p11C-specific cells during acute infection by 3.2-
and 1.5-fold, respectively (Table 2). However, no genes were found
differentially expressed on day 70. During late chronic infection,
LAG3 was expressed at increased levels in the dominant p11C-
specific cells (1.7-fold). Therefore, the dominant p11C-specific cells
showed higher expression of exhaustion-associated genes than the
subdominant p54AS-specific cells.
High TCR:pMHC affinity correlates with the epitope
dominance
We were interested in identifying mechanisms underlying the
differences in the frequency and function of epitope-specific cells
within an immunodominance hierarchy. Since TCR:pMHC
interactions can influence T cell activation, proliferation, and
function [43–49], we considered that TCR:pMHC interactions
might play a role in the establishment of the magnitude or of the
functionality of CD8+ T cells within an immunodominance
hierarchy. We employed a surface plasmon resonance (SPR)-based
Figure 2. Genes differentially expressed between dominant p11C- and subdominant p54AS-specific CD8+ T cells. The median of the
normalized expression values, measured in fluorescence units, of A) maturation, B) cytotoxicity, and C) proliferation and apoptosis genes that were
found to be differentially expressed between the p11C- and p54AS-specific cells on at least one time point are shown for each timepoint evaluated
during the first 70 days following SIVmac251 infection. The expression of these genes by total naı¨ve CD8+ T cells, measured on day 0, is also shown.
For those genes with more than one probe on the BeadChip, the numerical probe IDs are included in the gene name. * indicates that expression met
the criteria for differential expression on that timepoint.
doi:10.1371/journal.ppat.1004069.g002
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Figure 3. Phenotype and cytotoxic potential of dominant and subdominant epitope-specific cells during chronic SIVmac251 and
SIVsmE660 infection. The frequency, cell surface phenotype, and ex vivo perforin and granzyme B content were evaluated for p11C-, p54AS/E660-,
and p68A-specific cells, identified with Mamu-A*01 tetramers, from peripheral blood of chronically infected SIVmac251- and SIVsmE660- infected
rhesus monkeys. A) Frequencies of the p11C-, p54AS/E660-, and p68A-specific cells from (top) SIVmac251- and (bottom) SIVsmE660- infected rhesus
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technique developed in our laboratory that assesses the interaction
of TCRs from a polyclonal epitope-specific CD8+ T cell population
with monomeric pMHC complexes [50] to evaluate the role of
TCR:pMHC binding in determining the Mamu-A*01-restricted
epitope immunodominance hierarchy.
For initial measurements of the binding of the p11C-, p54E660-
, and p68A-specific TCRs to their respective monomeric pMHC
complexes, we sorted total CD8+ T cells from seven Mamu-A*01+
SIVsmE660-infected monkeys. Detergent-resistant micro-domain
(DRM) preparations from sorted cells, which were enriched in
TCR complexes, were immobilized onto a Biacore L1 chip. Initial
assays demonstrated that specific binding to DRM preparations
could be detected using monomers constructed with the dominant
p11C and subdominant p54E660 epitope peptides (Figure 6A and
Figure S8). The binding signal from the p54E660 monomers was
weaker than that of the p11C monomers at the same concentra-
tion. We were unable to detect specific binding of the monomers
constructed with the more subdominant p68A epitope peptide at
any of the concentrations of monomers (25–150 mg/mL) that were
initially evaluated (Figure 6A).
monkeys. Error bars indicate median 6 interquartile range. SIVmac251 frequencies measured between weeks 37–50, except for 133-06 which died
early and data presented are from week 18. SIVsmE660 frequencies are measured between weeks 19–22. B) Phenotyping of cells from SIVmac251-
(top, n = 4) and SIVsmE660-infected monkeys (bottom, n = 8) based on cell surface expression of CCR7 and CD28. Positivity for CCR7 and CD28 is
indicated by the + and2 signs below the bar graph. Cells were categorized as central memory (CCR7+CD28+), transitional memory (CCR72CD28+), or
effector memory (CCR72CD282). All tetramer-positive cells were CD95+. Phenotyping was conducted between weeks 44–78 for SIVmac251 and 33–
46 for SIVsmE660. C) Measurement of percent of ex vivo perforin+granzyme B+ cells from SIVmac251- (Left, n = 5) or SIVsmE660-infected monkeys
(right, n = 8). D) Per-cell expression of perforin and granzyme B, measured by geometric mean of fluorescence (GMF) of perforin and granzyme B
staining on cells from SIVmac251- (left, n = 5) and SIVsmE660-infected monkeys (right, n = 8). Perforin and granzyme B measurements were conducted
between weeks 63–83 for SIVmac251 and 41–49 for SIVsmE660. In parts B–D, error bars represent mean 6 SEM. * and **, significant at p#0.05 and
0.01, respectively, after Bonferroni correction. NS, not significant.
doi:10.1371/journal.ppat.1004069.g003
Figure 4. The dominant p11C-specific cells exhibited decreased antigen-specific expansion compared to subdominant epitope-
specific cells. PBMCs from monkeys chronically-infected with either SIVmac251 (A) or SIVsmE660 (B) were stimulated in vitro with either p11C (red),
p54E660/AS (blue), or p68A (green) peptide, harvested on days 3, 4, 5, 6, 8, 10, 12, and 14 following stimulation, and measured by flow cytometry to
calculate the percent of tetramer-positive CD8+ T cells. Expansion was calculated as the fold change of the percent of each tetramer-positive
population on each day, relative to day 0. Data from three SIVmac251- and three SIVsmE660-infected monkeys are shown. Measurements were
conducted between weeks 40–52 for SIVmac251 and 31–44 for SIVsmE660.
doi:10.1371/journal.ppat.1004069.g004
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We performed titrations of the p11C and p54E660 pMHC
monomers on DRM preparations from all seven monkeys
(Figure 6B and Figure S9) and used a 1:1 Langmuir curve fitting
analysis to calculate the association rate (ka) and the dissociation
rate (kd) of the TCR:pMHC binding interaction (Table 3). The
p11C:Mamu-A*01 monomers bound to the DRM samples with a
median kon of 7.38610
3/Ms (range 3.56–28.66103/Ms), which
was faster than the p54E660:Mamu-A*01 monomers that had a
median kon of 0.96610
3/Ms (range 0.66–1.876103/Ms). The
dissociation rate of p11C:Mamu-A*01 monomers from DRMs
(median koff 0.024/s, range 0.015–0.030/s) was not substantially
different from that of p54E660:Mamu-A*01 monomers (median
koff of 0.033/s, range 0.021–0.061/s). The apparent dissociation
constants (Kd) were derived from the kinetic rate constant values
and showed that the p11C:Mamu-A*01 monomers had a lower
median Kd (2.0 mM, range 1.0–6.8 mM) than the
p54E660:Mamu-A*01 monomers (32 mM, range 22–43 mM).
Thus, monomers constructed with the dominant p11C peptide
epitope exhibited faster association rates to chip-immobilized
DRMs, resulting in higher affinities (lower Kd) to TCRs than
monomers constructed with the subdominant p54E660 epitope
peptide.
We speculated that the inability to detect the binding of
p68A:Mamu-A*01 monomers to the DRM preparations may be
due to a substantially lower affinity of the p68A:Mamu-A*01
complex for its cognate TCRs. The difficulty in detecting binding
was also likely exacerbated by the low frequency of the p68A-
specific cells, which would have resulted in underrepresentation of
the p68A-specific TCRs in the DRMs. Therefore, we pooled
DRMs from p68A-specific cells sorted from multiple time points.
These samples contained two- to six-fold more p68A-specific cells
than samples from the initial experiments.
Using these DRM preparations containing more p68A-specific
cells and using higher concentrations of p68A:Mamu-A*01
monomers (.100 mg/mL), we detected specific DRM binding
(Figure 6C and Figure S10). However, specific monomer binding
exhibited extremely fast association and dissociation rates and was
detected only at very high concentrations. As a result, reliable Kd
values could not be measured using global curve fitting analyses.
Our previous measurement of p11C and p54E660 pMHC
monomer binding to DRMs indicated that p11C had the fastest
association rate. The association rate of the p68A monomer to its
respective TCRs was at least as fast as the association of the
quantifiable p11C monomer, although likely to be even faster.
Therefore, we estimated that the kon for p68A was at least 10610
3/
Ms. Knowing that the Biacore instrument’s lower limit of
detection of dissociation is about 1/s, we estimated that the koff
of the p68A:Mamu-A*01 monomer from its respective TCRs was
at least as fast as 1/s. Using these estimated kon and koff, the
apparent Kd of the p68A monomer was estimated be at least
100 mM (Table 3).
Therefore, the calculated Kd values were lowest for p11C
monomers, intermediate for p54E660 monomers, and estimated
to be highest for p68A monomers. In summary, epitope
dominance was associated with the hierarchy of TCR affinities.
Affinity differences were driven by the fast association rate of the
dominant p11C epitope:Mamu-A*01 complex to its respective
TCRs and likely fast dissociation rate of the more subdominant
p68A:Mamu-A*01 complex.
Discussion
The development of an effective vaccine against a pathogen
such as HIV-1 will require a detailed understanding of the
interplay between epitope immunodominance and the functional
capacities of epitope-specific CD8+ T cells. The present study was
undertaken to explore this relationship in SIV-infected rhesus
monkeys.
It is important to note that our longitudinal gene expression
analyses were conducted with a restricted sample size of six
monkeys. In addition, because of the large numbers of cells
required for RNA isolation, we were unable to perform
phenotyping or functional assays during acute infection. Despite
these clear limitations, we were able to detect a number of
significant differences in gene expression between the dominant
and subdominant epitope-specific populations during acute
infection. Baron et al had similar findings, in a murine model,
where they characterized a dominant (H7a) and a cryptic (HY)
H2-Db–restricted epitope-specific CD8+ T cell population [20]. In
the murine model, the cryptic epitope-specific cells had higher
IL7R expression during primary expansion and higher L-selectin/
Figure 5. Dominant p11C-specific population contained lower frequency of cytokine- and chemokine-producing cells than
subdominant epitope-specific populations. PBMCs from monkeys chronically-infected with either SIVmac251 (n = 4) or SIVsmE660 (n = 5) were
stimulated with either p11C, p54AS/E660, or p68A peptides and intracellular staining was used to assess production of the chemokine MIP-1b and
cytokines IFNc, TNFa, and IL-2. Bars represent mean 6 SEM. A) Individual cytokine and chemokine production. Top, SIVmac251. Bottom, SIVsmE660.
B) Polyfunctional analysis. Positivity for each cytokine/chemokine is indicated by the dots below the bar graph. Vertical bars are grouped into 4, 3, 2
or 1 function (indicated by the pink, light blue, purple, and orange horizontal bars, respectively). C) Polyfunctionality charts. Left, SIVmac251. Right,
SIVsmE660. Each slice represents the percentage of tetramer-positive cells expressing between 1 and 4 functions. Data were collected between weeks
36–42 for SIVmac251 and 14–25 for SIVsmE660.
doi:10.1371/journal.ppat.1004069.g005
Table 2. Expression of exhaustion-associated genes.
Median Fold Change (p11C/p54AS)
Gene (Protein) Day 14 Day 70 Week 31/32
cd244 (2B4) 21.1 21.1 1.0
havcr2 (TIM-3) 21.0 21.1 1.1
lag3 (LAG-3) 3.2* 1.0 1.7*
pdcd1 (PD-1) 21.1 21.0 21.1
ctla4 (CTLA-4) 1.0 1.0 21.0
ctla4 1.5* 1.0 21.0
ctla4 21.1 21.1 1.0
prdm1 (BLIMP-1) 1.1 1.1 1.1
prdm1 21.0 21.2 21.0
prdm1 1.0 21.1 21.0
prdm1 21.2 21.1 21.0
cd160 (CD160) 21.1 21.2 21.2
tbx21 (T-bet) 1.1 21.1 21.1
eomes (Eomesodermin) 21.0 21.7 21.1
klrg1 (KLRG1) 21.1 1.1 1.2
klrg1 1.1 21.1 21.0
* p#0.05.
doi:10.1371/journal.ppat.1004069.t002
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SELL on all timepoints evaluated. Similarly, we found that both
IL7R and SELL were higher in the subdominant p54AS-specific
cells. Additionally, Baron et al found that GZMA was highly
expressed in the dominant epitope-specific CD8+ T cells. We
found a trend toward higher expression of GZMA and significantly
higher expression of GZMB and GZMK in the dominant epitope-
specific populations. This suggests that common gene networks are
involved in the regulation of dominant immunologic responses.
We also evaluated the expression of exhaustion-associated genes
between the dominant and subdominant epitope-specific cells. We
found that the dominant p11C-specific cells had increased
expression of genes encoding LAG-3 and CTLA-4 during acute
infection, both of which are known to be upregulated upon TCR
stimulation [51,52]. The role of these exhaustion-associated genes
during acute infection is not well established and it is unclear to
what extent these molecules impair CD8+ T cell function during
acute HIV/SIV infection. Their increased expression on the
dominant p11C-specific cells during acute infection suggests that
these cells were experiencing a greater level of activation driven by
greater stimulation through their higher-affinity TCRs. On day
Figure 6. TCR:pMHC measurements. DRMs were purified from total CD8+ T cells sorted from seven chronically-infected SIVsmE660-infected
monkeys. The DRMs were evaluated for specific binding, measured in resonance units (RU), to pMHC monomers constructed with p11C, p54E660,
and p68A epitope peptides and Mamu-A*01. Data are representative of the binding observed from all seven monkeys evaluated. A) Initial
experiments to detect p11C, p54E660, and p68A monomer binding to DRMs. 100 mg/mL p11C (red), 100 mg/mL p54E660 (blue), and 150 mg/mL p68A
(green) pMHC monomer binding are overlaid from experiments conducted on separate Biacore Chips. Binding of the p68A:Mamu-A*01 monomer to
the DRMs was not observed at any concentration of monomer tested (25–200 mg/mL). B) Titrations of p11C (top) and p54E660 (bottom)
peptide:Mamu-A*01 monomers for calculation of binding kinetics and affinity. Overlaid sensograms of the binding of p11C and p54E660 pMHC
monomers to DRMs purified from total CD8+ T cells are shown. Monomer binding was evaluated using pMHC concentrations ranging from 25 to
200 mg/mL. The black curve shows the Langmuir fitted curve that was used to calculate kinetics. C) Detection of p68A peptide:Mamu-A*01 monomer
binding to DRMs. p68A-specific CD8+ T cells were collected from multiple tetramer-specific flow cytometric cell sorts and pooled for DRM purification.
Titrations of p68A pMHC monomers were performed at concentrations ranging from 150 to 1000 mg/mL. Binding to DRMs from monkey ZD57 at
1000 mg/mL is shown and is representative of the four monkeys that were evaluated. All readings have been normalized by subtracting the binding
of the control monomer TL8 run at the same concentrations as the experimental monomers.
doi:10.1371/journal.ppat.1004069.g006
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70, no differences in gene expression were noted between the
dominant and subdominant epitope-specific cells. However, by
late chronic infection, the dominant p11C-specific cells showed
increased levels of LAG-3 transcripts. LAG-3 is a well-described
marker of exhausted CD8+ T cells during chronic viral infections
[53,54], including HIV [55]. However, while LAG-3 expression
on CD8+ T cells has been shown to contribute to immune
suppression in certain mouse models [56], its suppressive effect
during HIV/SIV infection remains unclear [57,58]. Additional
studies are needed to confirm the cell surface expression of this
protein and determine the extent to which increased expression
contributes to functional differences between dominant and
subdominant SIV/HIV epitope-specific cells.
In the present study, we found that dominant epitope-specific
cells had greater cytotoxic potential, whereas the subdominant
epitope-specific cells displayed enhanced proliferation capacity
combined with increased cytokine and chemokine production.
Importantly, these dominant epitope-specific cells had higher
TCR affinity, a measure that typically correlates with functional
avidity [59–61]. The ability of HIV/SIV epitopes with higher
functional avidity to induce T cells that are less polyfunctional with
lower proliferative capacity has been described by Harari et al [62]
and Vigano` et al [63]. These studies also corroborate our findings
that cells of increased avidity also exhibited increased expression of
exhaustion-associated molecules. Similarly, Conrad et al found that
dominant TCR clonotypes exhibited reduced in vitro cytokine
production and survival compared to the subdominant clonotypes
that was associated with increased TCR avidity and increased
expression of PD-1 [64]. These studies support the notion that
reduced CD8+ T cell avidity promotes the development of
polyfunctional T cells that under conditions of persistent high
antigenemia may be able to partially control viral replication. This
is also supported by the fact that increased avidity is significantly
associated with viral escape [65–67] and increased induction of
cell death and exhaustion [68,69]. Collectively, these studies are
consistent with our findings and suggest that to generate
polyfunctional T cells after vaccination, the antigens used cannot
confer extremely high TCR affinity; otherwise exhausted and
monofunctional T cells will be generated.
The finding that the dominant p11C-specific cells were not
highly polyfunctional is surprising considering that these cells are
thought to be predominantly responsible for control of SIV viral
replication [70,71]. This reduced polyfunctionality may be
compensated by a number of other cell characteristics. First, they
may possess higher functional avidity, a characteristic that also
correlates strongly with HIV control [15,60,72,73] and higher
TCR affinity [59–61]. Second, the dominant epitope-specific cells
are present at substantially higher frequencies and contain greater
amounts of perforin and granzyme than the subdominant epitope-
specific cells. Thus on a percentage basis, the former population
has an increased capacity to kill virus-infected cells. Finally, they
may have greater TCR cross-reactivity to epitope variants, a
characteristic that is thought to be an important component of
durable HIV control by CD8+ T cells [73,74]. In support of this
possibility, Mothe et al found that HIV controllers had higher
functional avidity that was associated with higher cross-reactivity
of CD8+ T cells to HIV epitope variants compared to non-
controllers [73]. Additionally, Bennett et al generated a panel of
mutant TCRs specific for the HIV epitope SL9 and found that
those TCR mutants with higher TCR avidities generally were
more cross-reactive to SL9 variants than those with lower avidities
[61]. In contrast, the previously-mentioned study by Conrad et al
found that the high TCR avidity of the dominant clonotypes had
reduced cross-reactivity than subdominant clonotypes [64]. Future
studies should compare the TCR cross-reactivity to variant
epitopes between the dominant p11C- and the subdominant
epitope-specific cells to determine the extent that it contributes to
the protective capacity of the p11C-specific cells.
We found that TCR affinity was predictive of frequency of the
dominant and subdominant epitope-specific cells that are gener-
ated. The role of TCR:pMHC interactions in determining
immunodominance hierarchies has been largely unexplored. A
limited number of murine studies that have addressed this by
measuring TCR dissociation rates using peptide:MHC class I
tetramers have either found a lack of association between TCR
affinity and epitope dominance [75] or found an association in the
opposite direction [76]. The discordance between these studies
and ours may be that for the measurement of the TCR
dissociation rate the mouse studies used pMHC tetramers as
opposed to monomers used in the present study. It is known that
the accuracy of pMHC tetramers to predict physiologic
TCR:pMHC binding affinities is limited [77,78]; The multi-
valency of tetramers combined with their propensity to aggregate
can complicate accurate measurement of these interactions [79].
Moreover, the present study found that overall binding affinity
(which incorporates both association and dissociation rate), rather
than dissociation rate alone, was predictive of epitope dominance.
In the above-mentioned murine studies, only the dissociation rate
was assessed, leaving the association rate and affinity unknown.
Slower association rates have been previously attributed to
induced-fit or thermodynamic entropic penalty [80–82] in TCR
binding and as such, pMHC epitopes that bind with faster
association rates may outcompete those that bind with slower
kinetic rates and gain dominance in response. Therefore, it is
possible that association rate also played a role in the
immunodominance hierarchies in these mouse studies and its
measurement may have been informative about the particular
parameter of the TCR:pMHC interactions that was important for
immunodominance.
The present study found that high-frequency dominant epitope-
specific CD8+ T cells had reduced proliferation and cytokine
production but increased cytotoxicity potential compared to low-
frequency subdominant epitope-specific CD8+ T cells. This was
associated with higher TCR affinity and increased expression of
exhaustion-associated genes in the dominant epitope-specific cells.
The engineering of higher-affinity TCRs has been explored for
enhancement of HIV immunity [61,83]. However, our findings
suggest that high TCR affinity may increase susceptibility to
exhaustion and reduced functionality, although it may also
Table 3. TCR:pMHC binding values.
kon (610
3M21s21) koff (s
21) Kd (mM)
p11C 7.38 (3.56–28.6) 0.024 (0.015–0.030) 2.0 (1.0–6.8)
p54E660 0.96 (0.66–1.87) 0.033 (0.021–0.061) 32 (22–43)
p68A $10* $1` $100{
Values are the median (range) from seven monkeys.
kon, association rate.
koff, dissociation rate.
Kd, equilibrium dissociation constant. Calculated using the equation koff/kon.
* kon of the p68A monomers was estimated as being at least as fast as the
fastest measured monomer, p11C.
`koff of p68A monomers was estimated as being at least as fast as the limit of
detection of the Biacore instrument, approx.1/s.
{Kd of p68A monomer binding calculated using estimated values of the kon and
koff using the equation koff/kon.
doi:10.1371/journal.ppat.1004069.t003
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promote higher cytotoxic potential. Since both proliferation and
cytokine production as well as cytotoxicity are associated with
superior control of HIV replication, antigen targets of engineered
TCRs or antigens that are included in an HIV vaccine should be
of both high and low affinity. The high-affinity antigens will
promote epitope-specific CD8+ T cells of high frequency with high
cytotoxic potential while the low-affinity antigens will promote
CD8+ T cells that are more polyfunctional and proliferative and
that have decreased potential for exhaustion.
Materials and Methods
Ethics statement
Indian-origin rhesus monkeys used in this study were main-
tained according to the guidelines of the National Institutes of
Health (NIH) Guide to the Care and Use of Laboratory Animals
and the approval of the Institutional Animal Care and Use
Committee (IACUC) of Harvard Medical School (protocol #
03503) and the NIH. The institution also accepts as mandatory the
Public Health Service Policy on Humane care and use of
Laboratory Animals by Awardee Institutions and the NIH
Principles for the Utilization and Care of Vertebrate Animals
used in Testing, Research and Training. The New England
Primate Research Center (NEPRC) is fully accredited by the
Association for Assessment and Accreditation of Laboratory
Animal Care International (AAALAC). The NEPRC has devel-
oped a comprehensive environmental enrichment, psychological
well-being, and minimization of distress plans for primates that is
available for inspection by the United States Animal and Plant
Health Inspection Service (APHIS) and to officials of any pertinent
funding agency. The Harvard Medical School IACUC documents
NEPRC compliance with the plan during semiannual facility
inspections.
Animals
Mamu-A*01-positive, Mamu-B*17-negative, Mamu-B*08-nega-
tive, Indian-origin rhesus monkeys (Macaca mulatta) were selected
for these studies by PCR-based MHC typing as previously
described [84]. All monkeys were infected intrarectally with either
SIVmac251 or SIVsmE660. SIVmac251 infection was adminis-
tered by a single high dose challenge. SIVsmE660 was adminis-
tered by a repeated low-dose challenge.
Antibodies and flow cytometry reagents
Conjugated antibodies and staining reagents included MIP-1b-
PE, CD3-PB, CD3-PE-Cy7, CD3-PerCP-Cy5.5, CD3-APC-Cy7,
CD3-Horizon V450, CD4-PerCP-Cy5.5, CD4-AmCyan, CD4-
FITC, CD8a-APC, CD8a-APC-Cy7, CD8a-AlexaFluor700,
CD8a-FITC, CD8a-APC-H7, CD69- ECD (Beckman Coulter),
CD20-Horizon V450, CCR7-FITC (R&D Systems), CD95-APC,
CCR7-PerCP-Cy5.5, CD28-PE-Cy7 (eBioscience), granzyme B-
AlexaFluor700, perforin-FITC (MabTech), IFNc-PE-Cy7, TNFa-
AlexaFluor700, IL-2-APC, CD95-PE, CD95-APC, and Aqua
LIVE/DEAD Fixable Dead Cell Stain (Invitrogen). All reagents are
from BD Biosciences unless indicated otherwise. For construction of
monomers and tetramers, the following peptides were synthesized
and purified to .95% by HPLC by New England Peptide LLC:
p11C (CTPYDINQM), p54AS (TVPWPNASL), p54E660
(TVPWPNETL), p68A (STPPLVRLV), and TL8 (TTPESANL).
The monomers and tetramers were prepared as previously
described [85,86]. Tetramers were prepared using either strepta-
vidin-PE (Prozyme), -APC (Prozyme), -AlexaFluor488 (Invitrogen),
or -Qdot655 (Invitrogen). Monomers used in surface plasmon
resonance studies were further quantified using an RC DC protein
kit (Bio-Rad).
RNA extraction and microarray analysis
Peripheral blood was collected on days 14, 21, 28, 35, 42, 56,
70, and at week 31 or 32 post-inoculation with SIVmac251.
Plasma viral RNA from these samples was measured using an
ultra-sensitive branched DNA amplification assay (Siemens
Diagnostics, Berkeley, CA). PBMC were stained with p11C and
p54AS tetramers and CD3 and CD8 antibodies at 4uC. Tetramer-
positive single CD3+CD8+ lymphocytes were sorted to $95%
purity into RNAprotect (Qiagen) at 4uC. RNA was isolated using a
Trizol (Invitrogen) extraction protocol. Briefly, 0.8 ml of Trizol
were added to the cell pellet and incubated for 5 minutes at room
temperature and 0.16 ml of chloroform were added, shaken
vigorously by hand for 15 seconds, incubated at room temperature
for 2–3 minutes and centrifuged at 13,000 rpm for 15 minutes at
4uC. The colorless upper aqueous phase was carefully collected
and transferred to a new tube containing 2 ml of linear acrylamide
for mixing. An equal volume of isopropyl alcohol was then added
and mixed. The mixture was incubated at room temperature for
10 minutes and centrifuged at 13,000 rpm for 10 minutes at 4uC.
The supernatant was collected and the RNA was washed with
1 ml of 70% ethanol and centrifuged at 10,500 rpm for 5 minutes
at 4uC. The supernatant was completely removed and the RNA
pellet was allowed to air-dry. The RNA was then resuspended in
RNase-free water and stored at 280uC. RNA integrity was tested
using an Agilent Bioanalyzer. RNA was then amplified using the
TargetAmp 2-Round Biotin-aRNA Amplification Kit 3.0 (Epi-
centre Biotechnologies) according the manufacturer’s instructions.
Amplified biotinylated antisense-RNA (aRNA) was resuspended in
RNase-free water and stored at 280uC. Nanodrop ND-1000 was
used to determine the biotinylated aRNA concentration and an
Agilent Bioanalyzer was used to determine its integrity. Amplified
aRNA was hybridized to Illumina Human HT-12 Expression
BeadChips according to the manufacturer’s instructions and was
stained with Streptavidin Cy3 for detection (Illumina, San Diego,
CA, USA). The Human HT-12 BeadChip assays 48,000
transcripts. The BeadChips were built with sequences derived
from the National Center for Biotechnology Information Refer-
ence Sequence (NCBI RefSeq) database (Build 36.2, Release 22).
Arrays were scanned according to the manufacturer’s instructions.
Processing of the raw array data was performed using Illumina
BeadStudio software. Matlab (Mathworks, Natick, MA, USA) was
used to perform statistical analysis of gene expression data. The
entire expression dataset was first quantile-normalized. Fold-
differences of individual transcripts were computed as the ratios of
the median expression levels of the p11C- to those of the p54AS-
specific CD8+ T cells (p11C/p54AS). When p54AS expression
values were larger than p11C values, the negative reciprocal was
calculated. A Wilcoxon signed-rank test was used to evaluate the
significance of the differences in gene expression between p11C-
and p54AS-specific CD8+ T cells. Genes whose expression was
significantly different between the p11C- and p54AS-specific cell
samples and whose median fold change difference was at least
61.5 were considered differentially expressed. The Minimum
Information about a Microarray Experiment (MIAME) criteria
have been met by these experiments. The complete dataset is
available in the Gene Expression Omnibus, accession number
GSE54001.
Flow cytometric analysis
In order to collect and analyze comparable numbers of each
CD8+ T cell specificity, different numbers of PBMCs were used for
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each p11C, p54, and p68A sample. Input numbers of PBMCs
were dependent on the expected relative frequency of each
epitope-specific population. For example, if the expected frequen-
cies of the p11C-, p54-, and p68A-specific CD8+ T cells were
10%, 1%, and 0.1%, respectively, then the ratio of the numbers of
cells used for each sample was 1:10:100. Staining volumes,
washing volumes, and amounts of staining reagents used were
adjusted for each sample to ensure the same cell-to-reagent
concentration ratios were used for all samples. For quantification
of epitope-specific CD8+ T cells, PBMCs were stained with
tetramer and CD3, CD4, and CD8 antibodies. For phenotyping,
PBMCs were additionally stained with CD20, CD95, CD28, and
CCR7 antibodies. For ex vivo measurement of perforin and
granzyme B, PBMCs were stained with tetramer, CD3, CD4, and
CD8 antibodies and then stained intracellularly with perforin and
granzyme B antibodies as previously described [87]. FMO samples
were also prepared to set the gates for perforin and granzyme B
gating. All flow cytometric data were collected on an LSRII (BD)
and analyzed using FlowJo (Tree star). Statistical analysis of flow
cytometric data was conducted in GraphPad Prism 5. Wilcoxon
signed rank test was used to compare groups. P-values #0.05 were
considered significant. Bonferroni correction was used for multiple
comparisons with significant p-values #0.05/(number of compar-
isons) considered significant.
Cytokine and chemokine production
Measurements of IL-2, IFNc, TNFa, and MIP-1b production
by epitope-specific CD8+ T cells following stimulation of 1 nM
peptide was performed in 5 mL FACS tubes as previously
described [50]. Flow cytometric data were gated on single, live,
CD3+CD42CD8+CD69+ lymphocytes. Boolean gating was used
to calculate percent of polyfunctional cells.
Expansion of epitope-specific CD8+ T cells
PBMCs, at approximately 36106 lymphocytes/mL (measured
using Guava EasyCyte automatic cytometer (Millipore)), were
plated in flat-bottomed culture plates and stimulated for expansion
with 1 nM epitope peptide. Approximately 16106 PBMCs were
also stained with tetramers and CD3, CD4, and CD8 antibodies, to
measure the frequency each CD8+ T cell specificity before peptide-
stimulated expansion (day 0). 20 U/mL IL-2 (Hoffmann-LaRoche)
was added to stimulated cells on day 3, and media supplemented
with IL-2 was changed thereafter as needed. Samples were
harvested on days 3, 4, 5, 6, 8, 10, 12, and 14 post-stimulation for
staining with aqua LIVE/DEAD, tetramer and CD3, CD4, and
CD8 antibodies for flow cytometric analysis. Flow cytometric data
were gated on single, live, CD3+CD42CD8+ tet+ lymphocytes.
Surface plasmon resonance (SPR) measurements
Freshly isolated PBMCs were enriched for CD8+ T lymphocytes
using Miltenyi’s magnetic-activated cell sorting (MACS) kit for
isolation of untouched NHP CD8+ T cells according to the
manufacturer’s instructions. Isolated CD8+ T cells were then
stained at 4uC with tetramers and CD3 and CD8 antibodies.
Sorting was performed on an Aria flow cytometer/cell sorter (BD).
For initial TCR binding analyses, cells were only stained with the
TL8 tetramers and those cells that were positive for TL8 were
excluded from the sorted CD3+CD8+ lymphocytes. For repeated
TCR binding analysis for enrichment of p68A-specific TCRs, cells
were stained with TL8, p54E660, and p68A tetramers, and
multiple populations were simultaneously sorted: p54E6602
p68A2 TL82, p54E660+ p68A2 TL82, and p54E6602 p68A+
TL82. These sorted populations were subsequently combined
during purification of the DRMs. For samples with low total cell
number, extra DRMs from cells not specific for any of the epitopes
being evaluated were added to provide extra mass to the pellet
during centrifugation. These extra DRMs were obtained from
sorted single CD3+CD8+ lymphocytes that were negative for all
evaluated epitope specificities (p11C2p54E6602p68A2TL82). All
sorted cells were resuspended in a 4uC solution of protease
inhibitors (1 mg/mL each leupeptin, pepstatin, and aprotinin) and
stored at 280uC until analysis. DRM purification was carried out
as described previously [50] with the modification that the repeat
samples for measurements of p68A were conducted at concentra-
tions up to 1,000 mg/mL of monomer. The specific binding signal
was obtained by subtracting the non-specific signal from TL8
pMHC control monomer binding to the TL8-depleted DRM
preparation when injected at the same concentration from the
p11C, p54E660, or p68A binding signal. The global curve fitting
to the Langmuir equation was used to derive kinetic rate constants
(kon and koff) for calculation of equilibrium dissociation constant Kd
as previously described [88,89]. All SPR measurements were
carried out on a Biacore 3000 instrument, and data analyses were
performed using BIAevaluation 4.1 software (GE Healthcare).
Supporting Information
Figure S1 Gating of p11C- and p54AS-specific CD8+ T
cells sorted for microarray analyses. Gates for p11C (y-
axis) and p54AS (x-axis) tetramers on samples sorted from each of
the six Mamu-A*01+ rhesus monkeys (107-06, 112-06, 125-06, 133-
06, 142-06, and 202-06) used in the gene expression analysis. Plots
are gated on single CD3+CD8+ lymphocytes and percent of
tetramer-positive cells are shown on each plot for the p11C- (upper
left) and p54AS- (middle right) positive cells. 50,000 CD8+ T cells
events are displayed for all samples except where indicated in
upper right corner of plots. The data file for 107-06 on day 56 was
corrupt and not available for re-analysis.
(TIF)
Figure S2 Individual values of genes differentially
expressed between dominant p11C- and subdominant
p54AS-specific CD8+ T cells. Shown are the individual
normalized expression, measured in fluorescence units, for each
A) maturation, B) cytotoxicity, and C) proliferation and apoptosis
gene that was determined to be differentially expressed between
p11C- and p54AS-specific cells. Plots include values for which its
matching pair is missing and therefore were not used in
determination of differential expression. Fold change values are
indicated in upper left corner. An asterisk under fold change values
is present if that gene met the criteria for differential expression on
that timepoint. For those genes with more than one probe on the
BeadChip, the numerical probe IDs are included in the gene
name. Red, p11C. Blue, p54AS.
(PDF)
Figure S3 Staining and gating of tetramers for quanti-
fication of epitope-specific cells in Mamu-A*01 immu-
nodominance hierarchies. Gating of p11C-, p54AS/E660-,
and p68A-specific CD8+ T cells from A) SIVmac251- and B)
SIVsmE660-infected animals. 50,000 CD8+ T cell events are
displayed on each flow plot. SIVmac251 frequencies were
measured between weeks 37–50, except for 133-06 which died
early and data used are from week 18. SIVsmE660 frequencies
were measured between weeks 19–22.
(TIF)
Figure S4 Representative flow staining and gating for
phenotyping. Representative staining and gating for phenotyp-
ing of tetramer-positive cells from (A) SIVmac251- and (B)
TCR Affinity and CTL Immunodominance Hierarchies
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SIVsmE660-infected monkeys. Left, Staining and gating of
tetramer-positive cells among CD8+ T cells (40,000 CD8+ T cell
events are shown). Right, staining and gating of CD28 (y-axis) and
CCR7 (x-axis) cell surface proteins among the tetramer-positive
cells (1,000 tetramer-positive events are shown). Phenotyping was
conducted between weeks 44–78 for SIVmac251 and 33–46 for
SIVsmE660.
(TIF)
Figure S5 Representative staining and gating of per-
forin and granzyme B. Mamu-A*01 tetramers were used to
identify p11C-, p54AS/E660-, and p68A-specific cells among
PBMCs from monkeys chronically-infected with either SIV-
mac251 or SIVsmE660. Perforin and granzyme B content within
the tetramer-positive cells were measured by flow cytometry. A)
FMOs used to set gates for perforin (left) and granzyme B (right).
For SIVmac251 (B) and SIVsmE660 (D), representative staining
and gating of tetramer-positive cells (left) and perforin+granzyme
B+ cells among the tetramer-positive cells (right). 250,000 CD8+ T
cells are shown on flow plots of tetramer staining. 1,000 tetramer-
positive events are shown on flow plots of perforin and granzyme B
staining. For SIVmac251 (C) and SIVsmE660 (E), histograms
illustrating fluorescence intensity of perforin (top) and granzyme B
(bottom) within the p11C (red), p54AS/E660 (blue), and p68A
(green) tetramer-positive cells. FMOs shown as filled gray
histograms. Measurements were conducted between weeks 63–
83 for SIVmac251 and 41–49 for SIVsmE660.
(TIF)
Figure S6 Representative staining and gating of tetra-
mers during in vitro expansion. PBMCs from monkeys
chronically-infected with either SIVmac251 (A) or SIVsmE660 (B)
were stimulated in vitro with either p11C, 54E660/AS, or p68A
peptide, harvested on days 3, 4, 5, 6, 8, 10, 12, and 14 following
stimulation, and measured by flow cytometry to calculate the
percent (upper right on each flow plot) of tetramer-positive CD8+
T cells. Expansion was calculated as the fold change (middle left
on each flow plot) of the percent of each tetramer-positive
population on each day, relative to day 0. Number of CD8+ T cell
events displayed are the same for pllC, p54AS/E660, and p68A
plots within a given day. Measurements were conducted between
weeks 40–52 for SIVmac251 and 31–44 for SIVsmE660.
(TIF)
Figure S7 Representative staining and gating for cyto-
kine and chemokine production. PBMCs from monkeys
chronically-infected with either SIVmac251 (A) or SIVsmE660 (B)
were stimulated with either p11C, p54AS/E660, or p68A peptides
and intracellular staining was used to assess production of the
chemokine MIP-1b and the cytokines IFNc, TNFa, and IL-2.
Left, representative staining and gating of tetramer-positive cells
(25,000 CD8+ T cell events are shown). Right, corresponding
staining and gating of MIP-1b, IFNc, TNFa, and IL-2 (250
tetramer-positive events are shown). Individual gates were then
used in a Boolean analysis for assessment of polyfunctionality.
Data was collected between weeks 36–42 for SIVmac251 and 14–
25 for SIVsmE660.
(PDF)
Figure S8 Detection of specific binding of p11C and
p54E660 peptide:Mamu-A*01 monomers to DRMs.
DRMs were purified from total CD8+ T cells sorted from seven
chronically-infected SIVsmE660-infected monkeys. The DRMs
were evaluated for specific binding, measured in resonance units
(RU), to pMHC monomers constructed with p11C, p54E660, and
p68A epitope peptides and Mamu-A*01. Shown are overlaid
readings of the binding of p11C (red) and p54E660 (blue) pMHC
monomers at 100 mg/mL. p68A:Mamu-A*01 monomer binding
above background was not detected at any concentration and is
not shown. Readings have been normalized by subtracting the
binding of the control monomer TL8 run at the same
concentrations as the experimental monomers.
(TIF)
Figure S9 Titrations of p11C and p54E660 peptide:-
Mamu-A*01 monomers for calculation of binding kinet-
ics and affinity. Shown are sensograms indicating the binding
of p11C (left) and p54E660 (right) pMHC monomers to DRMs
purified from total CD8+ T cells sorted from seven SIVsmE660-
infected monkeys. p11C monomers were run at 25 (green), 50
(pink), 100 (blue), and 200 (red) mg/mL. The ARB0 plot for p11C
shows a 150 mg/mL (light blue) run in place of the 100 mg/mL.
The AP34, ZD57, and A6V031 plots for p11C do not show the
200 mg/mL run. p54E660 monomers were run at 25, 50, 150, and
200 mg/mL for AP54, ARB0, 8B1, and AS47 and at 25, 100, and
200 mg/mL for AP34, ZD57, and A6V031. The ZD57 plot
includes an additional 50 mg/mL run. A Langmuir curve was fit to
each binding curve at each concentration and was used to
calculate binding kinetics. Readings have been normalized by
subtracting the binding of the control monomer TL8 run at the
same concentrations as the experimental monomers.
(PDF)
Figure S10 Detection of p68A monomer binding. p68A-
specific CD8+ T cells were collected from multiple tetramer-
specific flow cytometric cell sorts and pooled for DRM
purification. Titrations of p68A pMHC monomers were per-
formed at concentrations ranging from 150 to 1000 mg/mL. The
highest concentration evaluated is shown. Binding of the control
monomer TL8 at the same concentration has been subtracted
from all readings.
(TIF)
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